⌘K

Login Start Free

Home/Filings/4/0001209191-09-021634

4//SEC Filing

Starr David 4

Accession 0001209191-09-021634

CIK 0001302554other

View on SEC.gov Company Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 5:31 PM ET

Size

5.6 KB

Accession

0001209191-09-021634

Insider Transaction Report

Form 4

Period: 2009-04-07

Winston Pharmaceuticals, Inc.WPHM

Vice President and CFO

Transactions

Award
Common Stock Options
2009-04-07+75,000→ 75,000 total
Exercise: $1.53Exp: 2019-04-07→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]Such options vest in five equal annual installments, commencing 04/07/2010.

Documents

1 file

4
c83896_4x0.xmlPrimary
MAIN DOCUMENT DESCRIPTION

Issuer

Winston Pharmaceuticals, Inc.

CIK 0001302554

Entity typeother

Related Parties

1

filerCIK 0001447152

Filing Metadata

Form type: 4
Filed: Apr 14, 8:00 PM ET
Accepted: Apr 15, 5:31 PM ET
Size: 5.6 KB

View on SEC.gov